semaglutide push health GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US. . As research uncovers potential benefits beyond weight loss, experts are Semaglutide Microdose Program | Fierce

Odegard PS, Setter SM, Neumiller JJ

Ivy RX holds a 4.0 out of 5 rating on Trustpilot based on over 5,100 verified reviews as of May 2026

Whether they are natural or synthetic, their chemical structures are identical

Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.